financetom
Business
financetom
/
Business
/
IM-2 Launch On Track For Next Week: What's Going On With Intuitive Machines Stock Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IM-2 Launch On Track For Next Week: What's Going On With Intuitive Machines Stock Thursday?
Feb 20, 2025 8:42 AM

Intuitive Machines Inc ( LUNR ) shares are trading lower. On Thursday, the company provided an update on its planned IM-2 mission.

What Happened: Intuitive Machines ( LUNR ) announced its IM-2 mission Nova-C class lunar lander “Athena” completed all integration milestones in preparation for launch later this month.

The company noted that the lunar lander is now safely encapsulated within SpaceX’s payload fairing and is targeted for a multi-day launch window that opens no earlier than Feb. 26.

“Humanity has never witnessed three lunar landers enroute to the Moon at the same time, and Athena is ready to rise to the occasion,” said Intuitive Machines ( LUNR ) CEO Steve Altemus.

Check This Out: SpaceX CEO Elon Musk Says Making Mars ‘Self-Sustaining’ Will Take Up To Half A Century, Will Require ’10 Earth-Mars Transfer Windows’

Intuitive Machines ( LUNR ) made history last year when its moon lander "Odysseus" landed on the moon's surface. The mission marked the first time the U.S. had been on the moon since 1972.

The Intuitive Machines IM-2 mission is the company’s second as part of NASA’s Commercial Lunar Payload Services initiative, which aims to lay the foundation for future human missions and a long-term human presence on the moon.

LUNR Price Action: Intuitive Machines ( LUNR ) shares are approximately flat year-to-date. The decline on Thursday is likely tied to weakness in the broader market.

Intuitive Machines ( LUNR ) shares were down 5.08% at $18.60 at the time of publication Thursday, according to Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
Sep 9, 2024
Monday, Relay Therapeutics Inc. ( RLAY ) shared interim data for RLY-2608 from ReDiscover study, an ongoing first-in-human study, to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary antitumor activity of RLY-2608 alone, in combination with fulvestrant, and combination with fulvestrant and ribociclib or atirmociclib (Pfizer Inc ( PFE )‘s selective CDK4 inhibitor). The data showed that despite heavy pre-treatment,...
ProStar Seeking $2 Million from a  Private Placement of Share Units
ProStar Seeking $2 Million from a Private Placement of Share Units
Sep 9, 2024
11:30 AM EDT, 09/09/2024 (MT Newswires) -- ProStar Holdings ( MAPPF ) on Monday said it is raising $2 million in a non-brokered private placement of share units to raise funds for sales, marketing and working capital. The offering consists of up to 12.5-million units priced at $0.16 each and made up of a share and a three-year warrant to...
CorMedix Signs Contract for DefenCath Supply
CorMedix Signs Contract for DefenCath Supply
Sep 9, 2024
11:36 AM EDT, 09/09/2024 (MT Newswires) -- CorMedix ( CRMD ) said Monday it has signed a multiyear contract with an unnamed healthcare company to supply DefenCath to its facilities in the US. Shipments for DefenCath are expected to start in Q4, CorMedix ( CRMD ) said. DefenCath is indicated to reduce the incidence of catheter-related bloodstream infections in adult...
Citi CFO expects investment banking fees to rise 20% in third quarter
Citi CFO expects investment banking fees to rise 20% in third quarter
Sep 9, 2024
NEW YORK (Reuters) -Citigroup's ( C/PN ) investment banking fees are expected to jump 20% in the third quarter from a year earlier, Chief Financial Officer Mark Mason told investors at a conference in New York on Monday. The gains are being driven by a good pickup in activity across debt capital markets and mergers and acquisitions, Mason said. Meanwhile,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved